Clinical Trials | September 17, 2025
Enveric clears FDA feedback milestone, prepares IND submission for EB-003
IND application for EB-003 expected in early 2026
IND application for EB-003 expected in early 2026
Lenalidomide Capsules are indicated for the treatment of adult patients with Multiple myeloma
EU approval makes Novo Nordisk’s oral semaglutide the first and only oral GLP-1 RA to reduce cardiovascular death, heart attack and stroke
Designed as an “AI-as-a-Service” platform, VECURA aims to reduce the traditional therapeutic drug discovery timeline of 10–12 years to just a few hours.
RN3161 is engineered to reduce fat while preserving lean mass, setting it apart from current treatment options
Ascletis announces ultra-long-acting subcutaneous depot maintenance formulation of small molecule GLP-1R agonist ASC30 with 75-Day observed half-life in participants with obesity
Prior to this appointment, he served as Vice-Chancellor of Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur,
Advent acquired Zentiva from Sanofi in 2018 and transformed the company into a highly successful standalone business
The discussions are expected to pave the way for the creation of a consolidated national knowledge-sharing platform on IT-enabled Ayush services,
The hospital was recognised as a Winner (Medium) in the category of Best Academic Institution (Government/Private)
Subscribe To Our Newsletter & Stay Updated
